Cooper Cos. (NYSE: COO) reported Q2 EPS of $3.35, $0.26 better than the analyst estimate of $3.09. Revenue for the quarter came in at $719.5 million versus the consensus estimate of $690.6 million.

Commenting on the results, Al White, Cooper's President and CEO said, "I'm happy to report that CooperVision and CooperSurgical both posted all-time record quarterly revenues which drove record quarterly earnings. Our businesses have rebounded nicely from Covid lows and we're poised for success with daily silicone hydrogel lenses and myopia management leading CooperVision, and fertility and PARAGARD® leading CooperSurgical."

GUIDANCE:

Cooper Cos. sees FY2021 EPS of $13.20-$13.40, versus the consensus of $13.04. Cooper Cos. sees FY2021 revenue of $2.855-2.885 billion, versus the consensus of $2.83 billion.

For earnings history and earnings-related data on Cooper Cos. (COO) click here.